Small intestinal metabolism is central to whole-body insulin resistance
Giulia Angelini(Università Cattolica del Sacro Cuore), Geltrude Mingrone(University of the Sacred Heart), A. Bertuzzi(Institute for Systems Analysis), Guido Costamagna(Agostino Gemelli University Polyclinic), Marco Raffaelli(Università Cattolica del Sacro Cuore), Pier Luigi Marini(Carlo Forlanini Hospital), Ivo Boškoski(Università Cattolica del Sacro Cuore), Giovanni Casella(Sapienza University of Rome), James Casella-Mariolo(ASL Roma), Sofie Ahlin, Amalia Gastaldelli(National Research Council), Lidia Castagneto‐Gissey(Policlinico Umberto I), Stefan R. Bornstein(King's College London), Serenella Salinari(Sapienza University of Rome), Melania Gaggini(Istituto di Fisiologia Clinica)
Cited by 33
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
Bariatric Surgery and Long-term Cardiovascular Events
|JAMA|2012|1.6k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k